复方鳖甲软肝片联合复方甘草酸苷治疗代偿期肝硬化患者疗效观察

doi:10.3969/j.issn.1672-5069.2014.02.022

Abstract

Hu Cuilan,Liu Chungang, Yuan Yanmei.. Combination of Fufang Bijiaruangan tablet and glyeyrrhizin in the treatment of patients with compensated liver cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(2): 192-193.

References

[1] 程孟怀，邵鸣，吴青芳. 恩替卡韦联合复方鳖甲软肝片治疗乙型肝炎肝硬化患者疗效观察. 实用肝脏病杂志，2010，13（3）:207-208.
[2] 魏明禄.阿德福韦酯胶囊联合复方鳖甲软肝片治疗早期肝硬化临床观察. 实用心脑肺血管病杂志，2010，18（9）:1273-1274.
[3] 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎的诊断标准. 中西医结合肝病杂志，2001，11（1）:56-60.
[4] 赵科孝.恩替卡韦联合复方鳖甲软肝片治疗早期乙型肝炎肝硬化临床观察. 实用肝脏病杂志，2011，14（6）:461-462.
[5] 廖志雄，黄毅华. 阿德福韦酯联合复方鳖甲软肝片治疗慢乙肝早期肝硬化疗效观察. 湖北中医杂志，2009，31（12）:31-32.
[6] 过小叶.复方甘草酸苷注射液联合扶正化瘀胶囊治疗慢性乙型肝炎肝纤维化100 例. 现代中西医结合杂志，2011，20（32）:4083-4084.
[7] 上官新红，李利亚. 复方甘草酸苷软肝胶囊治疗慢性乙型肝炎肝纤维化.医药论坛杂志，2009，30（15）:72-73.
[8] 白雪松. 复方甘草酸苷治疗慢性乙型肝炎肝纤维化的临床观察. 中国医院药学杂志，2010，30（14）:1213-1215.
[9] 林小文.复方甘草酸苷联合川芎嗪对慢性乙型肝炎肝纤维化指标的影响及疗效观察. 实用临床医药杂志，2013，17（7）:39-40.
[10] 孟玉君. 复方鳖甲软肝片对早期肝硬化患者缓解门脉高压疗效观察. 临床肝胆病杂志，2008，24（1）:55-56.
[11] 欧阳洪.复方甘草酸苷联合复方鳖甲软肝片治疗代偿性乙型肝炎肝硬化的疗效观察.传染病信息，2008，21（5）:309-311.
[12] 潘敏. 复方甘草酸苷对慢性乙型肝炎患者肝纤维化指标和细胞因子的影响. 福建中医药，2010，41（5）:12-14.
[13] 靳华.复方鳖甲软肝片联合阿德福韦酯治疗乙型肝炎代偿期肝硬化患者60例. 中西医结合肝病杂志，2010，20（6）:365-366.
[14] 吴军伟.复方鳖甲软肝片与慢肝解郁胶囊治疗肝炎后肝硬化的临床评价. 中国实验方剂学杂志，2013，19（5）:327-329.
[15] 李智，徐礼通，樊和斌，等. 复方鳖甲软肝片治疗肝硬化患者脾功能亢进的疗效观察. 中西医结合肝病杂志，2011，21（2）:90-91.

Combination of Fufang Bijiaruangan tablet and glyeyrrhizin in the treatment of patients with compensated liver cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[6]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[7]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[10]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[11]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[12]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[13]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[14]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.
[15]	Han Meiling, Chen Ping. Antiviral therapy in patients with liver cirrhosis and thrombocytopenia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 466-469.